Xentuzumab Antibody
Xentuzumab (BI836845) is a humanized monoclonal antibody that blocks IGF1 and IGF2 signaling, thereby inhibiting AKT activation and tumor growth. It is utilized in preclinical research for studying solid tumors, including breast and prostate cancers, in both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
IGF-1R, IGF1R, BI 836845, Akt
Target
Akt, IGF-1R
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Signal Transduction
Concentration
10.88 mg/mL
Purity
>95.0% (May vary between batches)
Molecular Weight
143.7 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
SP-86745-1 1 mg
CC Chemokine Receptor 3 Fragment I, amide (AA: Met-Thr-Thr-Ser-Leu-Asp-Thr-Val-Glu-Thr-Phe-Gly-Thr-Thr-Ser-Tyr-Tyr-Asp-Asp-Val-Gly-Leu-Leu-Cys-Glu-Lys-Ala-Asp-Thr-Arg-NH2) (MW: 3332.68)
Sign In for Pricing
View Details 
MBS1028346 Inquire
Recombinant Penicillium marneffei Pentafunctional AROM polypeptide 1 (aroM-1), partial
Sign In for Pricing
View Details 
A07547-1-FITC 100 µg/Vial
Anti-GPT2 Antibody Picoband® FITC Conjugated
Sign In for Pricing
View Details